Scohia Wants to Make Its “Carve Out” a Success Model for Japan Makers: CEO

Scohia Pharma CEO Yoichi Okumura As Takeda Pharmaceutical reworked its R&D strategies, the company pondered what to do with its renal, metabolic, and cardiovascular pipelines that might be promising but are no longer its core area. The answer was to...read more